Amalgamated Bank Moderna, Inc. Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Moderna, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 65,674 shares of MRNA stock, worth $2.6 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

65,674

Previous 66,775 1.65%

Holding current value

$2.6 Million

Previous $7.93 Million 44.65%

% of portfolio

0.04%

Previous 0.07%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$63.64 - $125.14 $70,067 - $137,779	-1,101 Reduced 1.65%	65,674 $4.39 Million
Q2 2024 Aug 12, 2024	SELL	$101.21 - $166.61 $213,553 - $351,547	-2,110 Reduced 3.06%	66,775 $7.93 Million
Q1 2024 Apr 23, 2024	SELL	$85.37 - $115.44 $907,056 - $1.23 Million	-10,625 Reduced 13.36%	68,885 $7.34 Million
Q4 2023 Feb 06, 2024	SELL	$69.51 - $104.43 $383,625 - $576,349	-5,519 Reduced 6.49%	79,510 $7.91 Million
Q3 2023 Nov 08, 2023	BUY	$96.41 - $126.61 $70,282 - $92,298	729 Added 0.86%	85,029 $8.78 Million
Q2 2023 Aug 11, 2023	SELL	$118.5 - $160.53 $180,001 - $243,845	-1,519 Reduced 1.77%	84,300 $10.2 Million
Q1 2023 May 02, 2023	SELL	$135.66 - $197.02 $140,408 - $203,915	-1,035 Reduced 1.19%	85,819 $13.2 Million
Q4 2022 Feb 10, 2023	SELL	$118.38 - $210.04 $14,442 - $25,624	-122 Reduced 0.14%	86,854 $15.6 Million
Q3 2022 Nov 09, 2022	SELL	$118.07 - $194.18 $133,655 - $219,811	-1,132 Reduced 1.28%	86,976 $10.3 Million
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $453,995 - $684,462	-3,876 Reduced 4.21%	88,108 $12.6 Million
Q1 2022 Jun 30, 2022	BUY	$126.46 - $235.05 $499,517 - $928,447	3,950 Added 4.49%	91,984 $15.8 Million
Q4 2021 Feb 15, 2022	BUY	$225.82 - $368.51 $1.97 Million - $3.22 Million	8,744 Added 11.03%	88,034 $22.4 Million
Q3 2021 Oct 29, 2021	BUY	$221.9 - $484.47 $12.1 Million - $26.5 Million	54,655 Added 221.86%	79,290 $30.5 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $1.38 Million - $2.49 Million	10,585 Added 75.34%	24,635 $5.79 Million
Q1 2021 May 13, 2021	SELL	$109.18 - $185.98 $91,274 - $155,479	-836 Reduced 5.62%	14,050 $1.84 Million
Q4 2020 Feb 12, 2021	SELL	$65.74 - $169.86 $14,331 - $37,029	-218 Reduced 1.44%	14,886 $1.56 Million
Q3 2020 Oct 30, 2020	BUY	$54.34 - $94.85 $34,723 - $60,609	639 Added 4.42%	15,104 $1.07 Million
Q2 2020 Aug 10, 2020	SELL	$29.67 - $80.0 $1.23 Million - $3.32 Million	-41,451 Reduced 74.13%	14,465 $929,000
Q1 2020 May 13, 2020	BUY	$17.78 - $31.58 $47,454 - $84,287	2,669 Added 5.01%	55,916 $1.68 Million
Q4 2019 Feb 13, 2020	BUY	$13.93 - $21.28 $51,387 - $78,501	3,689 Added 7.44%	53,247 $1.04 Million
Q3 2019 Nov 13, 2019	BUY	$12.26 - $18.07 $607,581 - $895,513	49,558 New	49,558 $789,000

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.5B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Moderna, Inc. Transaction History